Aviva’s Arrowhead Research ARWR Stock Holding History

Aviva’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,294	Closed	-$457K	–	860
2026 Q1	$457K	Buy	+7,294	New	+$462K	﹤0.01%	721
2020 Q1	–	Sell	-39,122	Closed	-$2.48M	–	939
2019 Q4	$2.48M	Buy	+39,122	New	+$1.94M	0.02%	623

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Aviva's ARWR Position: Q2 2026 in Review

Aviva sold out of Arrowhead Research (ARWR) in Q2 2026, closing a stake of 7,294 shares — an estimated $457K sold.

Aviva first reported a position in ARWR in Q4 2019 and held it in 2 quarters. The position peaked at $2.48M in Q4 2019. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Aviva reported no remaining Arrowhead Research position as of Q2 2026 after selling out during the quarter.
Aviva sold 7,294 Arrowhead Research shares in Q2 2026, an estimated $457K.
Aviva first reported a position in Arrowhead Research in Q4 2019 and held it in 2 quarters.
Aviva's Arrowhead Research position peaked at $2.48M in Q4 2019.
500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.